Clinical trial tests psilocybin-assisted therapy for depression in advanced lung cancer patients It’s the first trial specific to lung cancer using hallucinogenic mushroom-assisted therapy
Nearly 40% of people with lung cancer experience depression, and many also face anxiety, hopelessness and questions about mortality after diagnosis. Researchers at The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer…
